Inceptionr LLC Boosts Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Inceptionr LLC raised its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 159.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 24,773 shares of the company's stock after purchasing an additional 15,225 shares during the quarter. Inceptionr LLC's holdings in Bath & Body Works were worth $960,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in BBWI. FMR LLC lifted its position in shares of Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock worth $80,315,000 after purchasing an additional 2,501,828 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Bath & Body Works by 13.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock worth $66,088,000 after buying an additional 195,813 shares during the last quarter. KBC Group NV increased its stake in Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company's stock valued at $54,322,000 after purchasing an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH bought a new stake in Bath & Body Works in the third quarter valued at approximately $50,483,000. Finally, Forest Avenue Capital Management LP increased its stake in Bath & Body Works by 19.1% in the third quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company's stock valued at $46,851,000 after purchasing an additional 235,173 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a research report on Thursday, November 21st. Argus restated a "hold" rating on shares of Bath & Body Works in a report on Friday, January 10th. Barclays reduced their target price on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a report on Monday, March 3rd. Wells Fargo & Company upgraded shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Finally, Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and increased their target price for the stock from $40.00 to $48.00 in a report on Friday, February 28th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works has an average rating of "Moderate Buy" and an average target price of $45.06.

Bath & Body Works Stock Down 4.5 %

BBWI traded down $1.54 during trading on Friday, hitting $32.66. 4,652,756 shares of the company's stock were exchanged, compared to its average volume of 3,886,149. The business's 50 day moving average is $37.25 and its two-hundred day moving average is $34.17. The stock has a market cap of $7.07 billion, a P/E ratio of 7.97, a PEG ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works's payout ratio is 21.98%.

Bath & Body Works announced that its Board of Directors has initiated a share repurchase program on Thursday, February 27th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 6.4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.